Navigation Links
Positron And iThemba LABS Enters Into Radioisotope Supply Agreement
Date:7/29/2013

CHICAGO, July 29, 2013 /PRNewswire/ -- Positron Corporation (OTCBB:POSC) announces it has entered into a multi-year radioisotope supply agreement with iThemba LABS of Cape Town, South Africa.  The supply agreement contracts the procurement of raw material, strontium-82 (Sr-82) from iThemba LABS for further production of the Active Pharmaceutical Ingredient (API) at Positron's radioisotope production facility in Lubbock, TX.  In September 2013, Positron will receive relevant volumes of strontium-82 for qualification and will commence with commercial availability beginning in February 2014. This additional supply will enhance the industry's strontium-82 supply and increase the availability of radiopharmaceuticals to the end user. Positron intends to make this Sr-82 API supply available to all rubidium-82 generator producers in the marketplace. 

The iThemba Laboratory for Accelerator-Based Sciences (LABS) is a group of multi-disciplinary research laboratories administered by the National Research Foundation of South Africa. The iThemba LABS facility provides basic and applied research using particle beams, particle radiotherapy for the treatment of cancer and the supply of accelerator-produced radioactive isotopes for nuclear medicine and research. The Radionuclide Production Department has been producing radiopharmaceuticals and radionuclides for the past 23 years, some of them include 67Ga-citrate, 123I-products, 18F-FDG, 68Ge/68Ga generators, 22Na UHV positron sources and 82Sr (irradiated Rb or RbCl targets).  iThemba LABS is the largest facility of its kind in the Southern Hemisphere and one of six facilities in the world that can produce Sr-82 with a proton accelerator.

"Over the past 15 years, iThemba LABS has played an integral role in supplying a significant portion of the global Sr-82 supply," states Jason Kitten, Executive Director of Radioisotopes for Positron.  "During my tenure, with the U.S. Department of Energy at Los Alamos National Laboratory, I came to recognize iThemba LABS as a global leader and am pleased to continue our relationship. This agreement is a true testament to our mutual commitment to cardiac PET and enhancing the reliability of this vital lifeline to the industry. This collaboration further advances and strengthens the progression of a successful technology transfer of the Sr-82 lifecycle, from the U.S. DOE to the private sector. We look forward to a mutually beneficial partnership, whereby iThemba LABS can assist in expanding the cardiac PET market in the U.S. through Sr-82 supply and Positron will assist in bringing the cardiac PET modality to the African continent with iThemba LABS leading the effort."

About Positron: Positron Corporation is a nuclear medicine healthcare company vertically integrating all the segments of nuclear cardiology, providing an end-to-end solution for cardiac PET.  Through proprietary PET imaging systems, radiopharmaceuticals and radioisotopes solutions, Positron enables healthcare providers to more accurately diagnose disease and improve patient outcomes, while practicing cost effective medicine. Positron's unique products, market position and approach in securing the supply chain are substantial advantages, further accelerating the adoption of cardiac PET and growth of nuclear cardiology.  Positron is redefining the industry.  More information about Positron is available at www.positron.com.

About iThemba LABS: iThemba (which means HOPE in Nguni languages) Laboratory for Accelerator Based Sciences is a National Research Facility administered by the National Research Foundation of South Africa. Located at two sites in Cape Town and Gauteng, the facility is committed to unleash African potential through knowledge creation, innovation and human capacity building. The infrastructure available at iThemba LABS is used to advance knowledge in the field of experimental nuclear physics and applications.

The particle beams available at the facility in Cape Town are used to:

  • Advance the fundamental understanding of the structure and reaction mechanisms governing interactions of charged projectiles with target nuclei;
  • Offer proton and neutron particle radiotherapy;
  • Produce radionuclides for medical and industrial applications;
  • Provide analysis techniques for applications in materials research.

The Radionuclide Production Department at iThemba LABS has been producing isotopes for the past 23 years and is currently one of six facilities in the world capable of producing Sr-82. More information on iThemba LABS is available at www.tlabs.ac.za.

Forward Looking Statements:  Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Positron Corporation to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Positron assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.  Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Positron Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Positron Consolidates Radiopharmaceutical & Radioisotope Facilities
2. Positrons Attrius PET Scanner Now Utilized In Alzheimers Imaging With Amyvid Agent
3. Neusoft Positron Medical Systems Receives ISO Certification and CE Mark for their Attrius PET System
4. Positron Appoints Charles Conroy As Chief Operating Officer
5. Positron Introduces Next Generation PosiRx Pharmacy Automation Systems
6. Positron And Biologics Modular Enter Into Co-Marketing Agreement
7. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
8. Positron Retains Investment Banking Firm Covington Associates To Lead Financing Of Cyclotron Project
9. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
10. Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis
11. CyberKnife System and the da Vinci Surgical System in Concord Medical Centers Achieve Over RMB 10 Million in Medical Revenue Since Opening in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2020)... , ... July 02, 2020 , ... ... at Medical Conditions that Chiropractors Treat. , “From migraines to anxiety to ... medical conditions,” according to the company. , Sourced from physician recommendations on ...
(Date:7/1/2020)... (PRWEB) , ... July 01, 2020 , ... Dexur’s analysis ... University Hospitals Ahuja Medical Center , Southwest General Health Center , and ... day episode for Hip & Knee replacement. Dexur’s value analysis tracks a patient’s episode ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... Stratodesk NoTouch OS is available on NComputing devices. Thanks to fantastic new growth ... Stratodesk have formed a new partnership that will make the full Stratodesk NoTouch ...
Breaking Medicine Technology:
(Date:7/4/2020)... ... July 03, 2020 , ... The latest ... latest content hub— Future Lab: COVID-19 R&D . , Future Lab ... and products within specific scientific niches. Since their launch four years ago, the ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... Safety Professional of the Year Award to Eric Simmons of Temecula, California. ... 250 nominations. Simmons, who holds a master’s degree in occupational safety and health ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... the clinical development of psychedelics and analogues, announces its core executive team. The ... natural product drug discovery, novel formulations, and as distinguished researchers within the cannabis ...
(Date:6/28/2020)... ... June 26, 2020 , ... PathAI, a global provider ... of an exploratory analysis of digital scoring of PD-L1 expression to assess response in ... #2017 at the 2020 American Association for Cancer Research (AACR) Annual Meeting. AACR was ...
(Date:6/28/2020)... (PRWEB) , ... June 28, 2020 , ... ... societies around the world, dedicates World Allergy Week, from June 28 to July ... caused by SARS CoV-2. , COVID-19, short for “coronavirus disease 2019”, is a ...
Breaking Medicine News(10 mins):